Susquehanna International Group’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,000
| Closed | -$284K | – | 12561 |
|
|
2024
Q1 | $284K | Buy |
8,000
+2,600
| +48% | +$104K | ﹤0.01% | 9824 |
|
|
2023
Q4 | $235K | Buy |
+5,400
| New | +$213K | ﹤0.01% | 10347 |
|
|
2023
Q3 | – | Sell |
-5,000
| Closed | -$206K | – | 12415 |
|
|
2023
Q2 | $206K | Sell |
5,000
-5,400
| -52% | -$260K | ﹤0.01% | 10215 |
|
|
2023
Q1 | $597K | Sell |
10,400
-9,900
| -49% | -$558K | ﹤0.01% | 8128 |
|
|
2022
Q4 | $1.14M | Buy |
+20,300
| New | +$1.03M | ﹤0.01% | 5888 |
|
|
2022
Q2 | – | Sell |
-8,100
| Closed | -$521K | – | 13331 |
|
|
2022
Q1 | $521K | Buy |
8,100
+4,600
| +131% | +$303K | ﹤0.01% | 8864 |
|
|
2021
Q4 | $234K | Sell |
3,500
-2,000
| -36% | -$135K | ﹤0.01% | 11098 |
|
|
2021
Q3 | $377K | Buy |
+5,500
| New | +$389K | ﹤0.01% | 10070 |
|
|
2021
Q2 | – | Sell |
-9,700
| Closed | -$670K | – | 12858 |
|
|
2021
Q1 | $670K | Sell |
9,700
-3,500
| -27% | -$237K | ﹤0.01% | 8773 |
|
|
2020
Q4 | $857K | Buy |
13,200
+3,500
| +36% | +$188K | ﹤0.01% | 7069 |
|
|
2020
Q3 | $458K | Buy |
9,700
+4,900
| +102% | +$233K | ﹤0.01% | 7859 |
|
|
2020
Q2 | $226K | Sell |
4,800
-45,900
| -91% | -$2.26M | ﹤0.01% | 8822 |
|
|
2020
Q1 | $2.27M | Buy |
50,700
+45,000
| +789% | +$2.36M | ﹤0.01% | 3748 |
|
|
2019
Q4 | $332K | Sell |
5,700
-48,900
| -90% | -$2.91M | ﹤0.01% | 7834 |
|
|
2019
Q3 | $3.28M | Buy |
54,600
+1,700
| +3% | +$101K | ﹤0.01% | 3350 |
|
|
2019
Q2 | $2.95M | Buy |
52,900
+27,100
| +105% | +$1.4M | ﹤0.01% | 3479 |
|
|
2019
Q1 | $1.44M | Buy |
+25,800
| New | +$1.31M | ﹤0.01% | 4307 |
|
|
2018
Q4 | – | Sell |
-7,800
| Closed | -$514K | – | 9367 |
|
|
2018
Q3 | $514K | Sell |
7,800
-17,400
| -69% | -$1.08M | ﹤0.01% | 6462 |
|
|
2018
Q2 | $1.62M | Buy |
+25,200
| New | +$1.56M | ﹤0.01% | 4395 |
|
|
2017
Q4 | – | Sell |
-30,300
| Closed | -$1.53M | – | 9528 |
|
|
2017
Q3 | $1.53M | Buy |
30,300
+21,200
| +233% | +$1.09M | ﹤0.01% | 4418 |
|
|
2017
Q2 | $496K | Sell |
9,100
-6,400
| -41% | -$306K | ﹤0.01% | 6657 |
|
|
2017
Q1 | $653K | Buy |
15,500
+2,100
| +16% | +$89.7K | ﹤0.01% | 5990 |
|
|
2016
Q4 | $575K | Buy |
+13,400
| New | +$545K | ﹤0.01% | 6689 |
|
|
2016
Q3 | – | Sell |
-29,000
| Closed | -$1.16M | – | 8683 |
|
|
2016
Q2 | $1.16M | Buy |
+29,000
| New | +$1.04M | ﹤0.01% | 4563 |
|
|
2015
Q3 | – | Sell |
-8,318
| Closed | -$229K | – | 9832 |
|
|
2015
Q2 | $229K | Buy |
+8,318
| New | +$222K | ﹤0.01% | 9058 |
|
|
2015
Q1 | – | Sell |
-13,211
| Closed | -$293K | – | 9621 |
|
|
2014
Q4 | $293K | Sell |
13,211
-4,159
| -24% | -$84.3K | ﹤0.01% | 8175 |
|
|
2014
Q3 | $352K | Sell |
17,370
-19,572
| -53% | -$390K | ﹤0.01% | 7781 |
|
|
2014
Q2 | $711K | Buy |
36,942
+16,392
| +80% | +$305K | ﹤0.01% | 6783 |
|
|
2014
Q1 | $386K | Buy |
20,550
+9,052
| +79% | +$175K | ﹤0.01% | 7185 |
|
|
2013
Q4 | $224K | Buy |
+11,498
| New | +$211K | ﹤0.01% | 8063 |
|
|
2013
Q3 | – | Sell |
-18,349
| Closed | -$275K | – | 8555 |
|
|
2013
Q2 | $275K | Buy |
+18,349
| New | +$269K | ﹤0.01% | 6941 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Susquehanna International Group's IART Position: Q1 2026 in Review
Susquehanna International Group opened a new position in Integra LifeSciences (IART) in Q1 2026: 25,745 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #11332 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in IART as recently as Q3 2025.
Susquehanna International Group first reported a position in IART in Q2 2013 and has held it in 39 quarters since. The position peaked at $12.2M in Q2 2018. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Susquehanna International Group held 25,745 shares of Integra LifeSciences worth $243K as of Q1 2026.
- Integra LifeSciences was a new Susquehanna International Group position in Q1 2026.
- Integra LifeSciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11332 holding.
- Susquehanna International Group first reported a position in Integra LifeSciences in Q2 2013 and has held it in 39 quarters since.
- Susquehanna International Group's Integra LifeSciences position peaked at $12.2M in Q2 2018.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.